COVID-19 Impact on Pharma Market Access & Pricing in Europe

Published on May 18, 2020
COVID-19 Impact on Pharma Market Access & Pricing in Europe
Ewgenij Trelenberg Mon, 05/18/2020 - 03:38pm
Watch on-demand

How has COVID-19 impacted pharma pricing and access? How can companies respond? In this short webinar, Partner and industry expert Robert Dumitrescu is joined by his colleague Marc Matar to discuss the implications and strategic responses under this ‘new normal’.

Additionally, you can learn more by reading their article.

Other news

A different perspective: How the healthcare industry is responding

May 18, 2020
A different perspective: How the healthcare industry is respondingOksana PrysiazhniukMon, 05/18/2020 - 12:35pm Share: Facebook Twitter LinkedIn Print this page Overview The healthcare industry is front-and-centre of the global response to the COVID-19 pandemic. From delivering the expertise and technologies to respond to the current health crisis, to researching

Surviving The Resurgent COVID-19 Crisis

May 18, 2020
Surviving The Resurgent COVID-19 Crisis Thinking right now about an “after corona” world – what we would normally call a recovery – will only divert resources from your company’s true existential challenge: surviving the wild roller coaster of the “with corona” period that will endure for the next 18 to 24 months until a vaccine becomes widely available. Commercial agility – a rare comb